rs6062486 — RTEL1 Telomere helicase immune variant

Intronic variant in RTEL1 (regulator of telomere elongation helicase 1) associated with atopic dermatitis risk; the A allele increases AD susceptibility through impaired telomere-dependent immune cell renewal

See your personal result for RTEL1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

RTEL1 rs6062486 — Telomere Maintenance and the Skin Immune Barrier

The RTEL1 gene encodes regulator of telomere elongation helicase 111 regulator of telomere elongation helicase 1
A DNA helicase that unwinds telomeric structures, prevents aberrant telomere recombination, and participates in genome-wide DNA repair; essential for maintaining telomere length during cell division, an enzyme critical to keeping the caps of chromosomes intact during cellular replication. While RTEL1 is best known from rare loss-of-function mutations causing dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome — severe telomere-shortening disorders — rs6062486 operates at a far subtler level. This common intronic variant does not impair RTEL1 protein function outright; rather, it appears to modulate RTEL1 expression or splicing in ways that subtly compromise immune cell telomere integrity over time, tipping the balance toward the chronic skin inflammation characteristic of atopic dermatitis.

The Mechanism

RTEL1 is required for telomere replication22 telomere replication
Telomeres are repetitive DNA sequences (TTAGGG) at chromosome ends that shorten with each cell division; RTEL1 unwinds G-quadruplex structures and D-loops that would otherwise stall replication forks at telomeres, allowing complete telomere copying. Immune cells — particularly T cells and B cells — undergo rapid proliferative bursts during immune activation, making them especially dependent on efficient telomere maintenance. When RTEL1 function is even modestly reduced, these high-turnover lymphocytes accumulate replicative stress33 replicative stress
DNA damage that builds up at stalled replication forks, triggering senescence or apoptosis pathways before cells have completed their programmed immune response faster than normal.

Studies in patients with monoallelic RTEL1 variants demonstrate the immunological consequence directly: blood lymphocytes from RTEL1 variant carriers showed measurably shortened telomeres and enhanced follicular T-cell apoptosis44 shortened telomeres and enhanced follicular T-cell apoptosis
Cells expressing PD-1, markers of exhaustion and senescence, with failure to sustain germinal center B-cell interactions — the machinery of antibody class-switching and long-term immune memory. This premature lymphocyte senescence impairs the sustained, organized immune response needed to resolve allergen challenges without defaulting to the chronic Th2-skewed inflammation driving atopic dermatitis lesions.

The rs6062486 A allele is intronic and does not produce a missense change. Its effect is presumed regulatory — influencing RTEL1 expression levels or mRNA stability in immune-relevant tissues, consistent with the gene's location in an intron near potential regulatory elements. RTEL1 protein is expressed in lymphocytes and macrophages, the precise cell populations mediating AD pathogenesis at the skin-immune interface.

The Evidence

The association between rs6062486 and atopic dermatitis is among the most robustly replicated non-HLA GWAS signals in the condition. The 2023 European and multi-ancestry GWAS meta-analysis55 2023 European and multi-ancestry GWAS meta-analysis
Budu-Aggrey et al., Nature Communications 2023; 85 previously confirmed and newly discovered loci across 180,834 cases reported OR 1.09 (95% CI 1.07–1.10, P=5.03×10⁻³⁰) in the discovery analysis, with replication in an independent 23andMe cohort of over one million participants yielding OR 1.07 (P=4.5×10⁻¹⁰⁹). The A allele effect allele frequency in Europeans is approximately 0.69, meaning the elevated-risk genotype is by far the most common state in European populations.

At the functional level, RTEL1's immunological role has been directly demonstrated through study of rare monoallelic RTEL1 variants in common variable immunodeficiency patients66 common variable immunodeficiency patients
CVID, a primary immunodeficiency defined by poor antibody production and recurrent infections; RTEL1 variants were found in four CVID patients with a distinctive T-cell exhaustion signature (PMID 35562849). The patients exhibited shortened lymphocyte telomeres, excess follicular T-cell apoptosis, and a PD-1-high exhaustion phenotype — a mechanistic chain running directly from RTEL1 → impaired telomere maintenance → premature immune cell senescence → impaired immune regulation.

The RTEL1-TNFRSF6B locus was also identified in an earlier independent eczema GWAS with OR 1.14 (P=1×10⁻⁸), consistent with the larger meta-analysis effect estimate and confirming the locus across multiple study populations.

The effect size (OR 1.07–1.09 per A allele) is modest, consistent with a common polygenic risk variant rather than a high-penetrance causal mutation. Carrying two A alleles (AA genotype, ~49% of Europeans) approximately doubles the per-allele effect relative to one copy.

Practical Implications

The AD risk conferred by rs6062486 operates through immune cell maintenance — a pathway distinct from the barrier dysfunction (FLG), Th2 signaling (IL-4/IL-13 pathway), and IL-17/IL-22 keratinocyte signaling that other AD loci address. This means the rs6062486 effect likely compounds with barrier and cytokine pathway variants, particularly for individuals carrying risk alleles at multiple independent AD loci.

Clinically, the genomic maintenance angle suggests that interventions supporting immune cell telomere health — such as targeted micronutrients that are RTEL1 pathway cofactors — may be specifically relevant for this genotype. Vitamin D, which modulates both telomere length and skin immune regulation, and zinc, an essential cofactor for DNA repair helicases, represent the most evidence-supported options for this specific mechanism.

Interactions

The RTEL1 locus is one of several genomic-maintenance loci among AD GWAS hits, alongside genes involved in DNA replication fidelity and chromatin organization. Its effect likely combines additively with IL-4 receptor pathway variants (IL4R, IL13) and skin barrier variants (FLG) in defining overall AD severity.

RTEL1 is expressed in alveolar macrophages and lymphocytes, explaining reported associations between RTEL1 variants and autoimmune-featured interstitial lung disease in familial pulmonary fibrosis cohorts (PMID 30523160) — different tissues, shared immune cell telomere maintenance mechanism.

Genotype Interpretations

What each possible genotype means for this variant.

GG Reference Genotype Normal

Reference allele homozygous — lowest RTEL1-associated atopic dermatitis risk

You carry two copies of the G (reference) allele at rs6062486. This uncommon genotype represents the lowest atopic dermatitis risk from this RTEL1 locus — you lack any copies of the A risk allele that drives OR 1.07–1.09 per allele for AD. The GG genotype is rare in most populations (approximately 9% of Europeans, 50% of East Asians, 6% of South Asians), making it notably more common among individuals of East Asian ancestry.

AG One Risk Allele Intermediate

One A allele — modestly elevated RTEL1-associated atopic dermatitis risk

The A allele at rs6062486 is intronic in RTEL1 and likely acts through regulatory effects on RTEL1 expression or splicing in immune cells. With one copy, the effect is approximately additive — you have partial reduction in RTEL1-mediated telomere maintenance in proliferating lymphocytes compared to GG carriers. Functional data from monoallelic RTEL1 variant carriers show measurable lymphocyte telomere shortening and enhanced T-cell apoptosis even with a single copy of a reduced-function allele, supporting the additive model.

AA Two Risk Alleles High Risk

Two A alleles — highest RTEL1-associated atopic dermatitis risk; most common European genotype

Homozygous AA individuals carry two copies of the RTEL1 risk haplotype at this locus. RTEL1 is expressed in both keratinocytes and circulating lymphocytes, and intronic regulatory variants like rs6062486 can reduce expression efficiency — meaning proliferating immune cells during allergen challenge may face a higher replicative stress burden than in GG carriers. Studies of monoallelic pathogenic RTEL1 mutations demonstrated shortened lymphocyte telomeres, accelerated T-cell exhaustion, and impaired germinal center reactions even with only one reduced-function allele; common regulatory AA homozygosity is expected to produce a subclinical version of the same biology.

The 2023 large-scale GWAS meta-analysis confirmed RTEL1 as annotated with "DNA repair" function — distinguishing this locus from barrier (FLG) or cytokine-signaling (IL4/IL13) AD loci. The RTEL1 genomic maintenance pathway likely compounds with those other mechanisms when multiple AD risk alleles coexist, explaining variation in disease severity between individuals who carry similar barrier and Th2 genetic risk profiles.